Prognostic Significance of SUVmax Combined With Lactate Dehydrogenase in Advanced Lung Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Retrospective Study

MLA

Linping Ke, et al. “Prognostic Significance of SUVmax Combined With Lactate Dehydrogenase in Advanced Lung Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Retrospective Study.” Frontiers in Oncology, vol. 11, May 2021. EBSCOhost, https://doi.org/10.3389/fonc.2021.652312.

APA

Linping Ke, Lu Wang, Jinming Yu, & Xue Meng. (2021). Prognostic Significance of SUVmax Combined With Lactate Dehydrogenase in Advanced Lung Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Retrospective Study. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.652312

Chicago

Linping Ke, Lu Wang, Jinming Yu, and Xue Meng. 2021. “Prognostic Significance of SUVmax Combined With Lactate Dehydrogenase in Advanced Lung Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Retrospective Study.” Frontiers in Oncology 11 (May). doi:10.3389/fonc.2021.652312.